IDEAYA Biosciences, Inc. (IDYA)
NASDAQ: IDYA · Real-Time Price · USD
30.00
+1.40 (4.90%)
Nov 4, 2024, 4:00 PM EST - Market closed
IDEAYA Biosciences Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
TTM
| FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
Net Income | - | -112.96 | -58.66 | -49.76 | -34.5 | -41.98 | |
Depreciation & Amortization | - | 4.01 | 3.52 | 3.03 | 1.38 | 1.25 | |
Loss (Gain) From Sale of Assets | - | - | - | - | 0 | 0.01 | |
Loss (Gain) From Sale of Investments | - | -11.55 | -0.7 | 1.83 | 0.56 | -0.48 | |
Stock-Based Compensation | - | 18.49 | 11.63 | 8.24 | 3.61 | 2.17 | |
Change in Accounts Receivable | - | 0.19 | 0.89 | 0.77 | -1.88 | - | |
Change in Accounts Payable | - | 2.64 | 1.86 | 1.17 | 0.23 | -0.2 | |
Change in Unearned Revenue | - | -13.75 | -46.48 | -23.54 | 83.77 | - | |
Change in Other Net Operating Assets | - | -2.28 | 0.75 | 2.48 | 2.29 | -0.09 | |
Operating Cash Flow | - | -115.22 | -87.18 | -55.78 | 55.46 | -39.31 | |
Capital Expenditures | - | -2.37 | -3.44 | -2.64 | -0.49 | -1.35 | |
Investment in Securities | - | -156.09 | -29.96 | -67.02 | -145.75 | 3.62 | |
Investing Cash Flow | - | -158.46 | -33.4 | -69.67 | -146.24 | 2.27 | |
Issuance of Common Stock | - | 320.54 | 97.17 | 145.45 | 128.75 | 50.61 | |
Other Financing Activities | - | 42.18 | - | - | - | - | |
Financing Cash Flow | - | 362.72 | 97.17 | 145.45 | 128.75 | 50.61 | |
Net Cash Flow | - | 89.04 | -23.41 | 20.01 | 37.97 | 13.56 | |
Free Cash Flow | - | -117.59 | -90.62 | -58.42 | 54.97 | -40.67 | |
Free Cash Flow Margin | - | -502.85% | -177.92% | -209.09% | 281.35% | - | |
Free Cash Flow Per Share | - | -2.04 | -2.19 | -1.66 | 2.22 | -3.25 | |
Cash Interest Paid | - | 0.07 | 0.06 | 0.07 | 0.08 | 0.09 | |
Cash Income Tax Paid | - | - | - | 0 | 0 | 0 | |
Levered Free Cash Flow | - | -70.28 | -42.37 | -15.64 | 11.39 | -27.22 | |
Unlevered Free Cash Flow | - | -70.28 | -42.37 | -15.64 | 11.39 | -27.22 | |
Change in Net Working Capital | - | 6.39 | 15.01 | -7.15 | -28.98 | 1.61 | |
Source: S&P Capital IQ. Standard template.
Financial Sources.